Table 1.
Animal Model | Polymer | Implantation Model | Duration | Compared to WT? | Measured Outcomes | Reference |
---|---|---|---|---|---|---|
| ||||||
hypogammaglobulinemic CB-17 SCID mice |
PET | intraperitoneal | 16 hours | Y | No change (leukocyte accumulation) | [86] |
B cells & T cells (deficient) CB-17 SCID mice |
PGA-P(CL/LA) & PLLA-P(CL/LA) | inferior vena cava & aorta | 21–42 days | N | No change (leukocyte accumulation, FBGC formation, collagen deposition, vascularization) | [84] |
T cells (deficient) BALB/C nude mice |
PEU & PET & SR | subcutaneous (cage implant) | 7–21 days | Y | No change (leukocyte accumulation*, FBGC formation) *Lower adherent cell densities in nude mice with PET at day 7 & PEU at day 21. |
[80] |
T cells (deficient) BALB/C nude mice |
PCL-Gelatin-HA | subcutaneous | 28–56 days | N | No change (fibrous encapsulation) | [82] |
NK cells (deficient) C57BL/6J mice |
||||||
NKT cells (deficient) BALB/CJ mice |
||||||
IL-4Ra (deficient) BALB/CJ mice |
PEU & PET | subcutaneous | 14–28 days | Y | No change (leukocyte accumulation, FBGC formation) | [83] |
mast cells (deficient) C57BL/6J mice |
||||||
B cells & T cells (deficient) C57BL/6J SCID mice |
||||||
T cells (deficient) BALB/C nude mice |
PCL-CaP | subcutaneous | 4–14 days | Y | No change (collagen deposition), vascularization ↑ | [81] |
IFN-γ (KO) C57BL/6 mice |
PE-PUR | subcutaneous | 7 days | Y | leukocyte accumulation ↓, vascularization ↓, pro-inflammatory cytokines ↓, anti-inflammatory cytokine ↑, collagen deposition ↓ | [97] |
MyD88 (KO) B6.129P2(SJL)- MyD 8 8 <tm 1.1Defr>/J mice |
PEG | subcutaneous | 2–28 days | Y | leukocyte accumulation ↓, fibrous encapsulation ↓, vascularization ↓ | [96] |
T cells (deficient) C57BL/6 nude mice |
PDMS | subcutaneous | 21 –42 days | Y | 0 |am, Ra: No change (leukocyte accumulation & fibrous encapsulation) 40 ^m, Ra: leukocyte accumulation ↑ & fibrous encapsulation ↑ | [141] |
IL-17A (KO) & IL-17RA (KO) C57BL/6J mice |
PCL | intramuscular | 42–84 days | Y | leukocyte accumulation ↓, fibrosis-related gene expression ↓, collagen deposition ↓, fibrous encapsulation ↓, fiber diameter ↓ | [10] |
B cells (KO) C57BL/6J muMt-mice |
PCL | intramuscular | 7–42 days | Y | No change (leukocyte accumulation), fibrosis-related gene expression ↓, collagen deposition ↓ | [79] |
B cells & T cells (deficient) CB-17 NOD SCID mice |
PVA | subcutaneous | 2–14 days | Y | No change (leukocyte accumulation) | [85] |
T cells (deficient) CBH-rnu/Arc nude rats |
PA-Gelatin | subcutaneous | 7–90 days | N | No change (leukocyte accumulation, vascularization, collagen deposition, fibrotic tissue ingrowth) | [110], [111] |
T cells (deficient) Sprague-Dawley nude rats |
PPF-pericardium | subcutaneous | 42 days | Y | No change (leukocyte accumulation) | [17] |